This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Dean Foods (DF) Stock Gains on Q1 Earnings & Sales Beat
by Zacks Equity Research
Dean Foods (DF) began 2018 on a solid note as first-quarter results outpaced the estimates. Further, its enterprise-wide productivity program to boost operational excellence is impressive.
Clorox (CLX) Q3 Earnings Beats Estimates, Trims '18 EPS View
by Zacks Equity Research
Clorox (CLX) delivered solid third-quarter fiscal 2018 results driven by its 2020 Strategy and other initiatives. However, management cut down its earnings guidance for the fiscal year.
Archer Daniels (ADM) Beats on Q1 Earnings & Sales, Up Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) impressive first-quarter 2018 results can be attributed to its robust strategic initiatives. With this, the company breaks its more than three-year long trend of sales misses.
Archer Daniels' Cost-Savings Plan on Track: Should You Buy?
by Zacks Equity Research
Archer Daniels (ADM) consistently gains from strategic initiatives like cost-savings efforts, meaningful acquisitions, organic growth projects undertaken and efficient portfolio management.
Archer Daniels' Realigned Business Units Shows Renewed Focus
by Zacks Equity Research
Archer Daniels (ADM) announced the realignment of the business segments into four units to boost growth across business portfolio.
Archer Daniels' Cost Savings on Track, Soft Sales a Concern
by Zacks Equity Research
Archer-Daniels-Midland (ADM) focuses on strengthening its business through increased cost savings. However, its top line has been lagging the estimates for over three years now.
Company News For Sep 13, 2017
by Zacks Equity Research
Companies in the news are: TEVA,WDC,AMZN,LMNR
Cosan (CZZ) Posts Profit in Q2, Maintains '17 Guidance
by Zacks Equity Research
Cosan Limited (CZZ) second-quarter 2017 results improved on a year-over-year basis, with adjusted net income of R$55.8 million comfortably surpassing a net loss of R$91.3 million in the year-ago quarter.
Volumes Dent Dean Foods (DF) Q2 Earnings & View, Stock Slumps
by Zacks Equity Research
Dean Foods Company's (DF) 2Q17 was hurt by a tough retail scenario. Further, volumes remained pressured owing to macro factors and stiff competition.
Boston Beer Stock Up 11.1% Since Q2 Earnings: Here's Why
by Zacks Equity Research
Shares of Boston Beer Company, Inc. (SAM) rose over 11% after it posted solid second-quarter 2017 results on Jul 27. Also, it raised the lower-end of previous earnings guidance range.
Tyson Foods Restructures Organization to Boost Efficiency
by Zacks Equity Research
Tyson Foods, Inc. (TSN) is streamlining the organizational structure in order to maximize growth and also boost the segments' efficiency by taking quick and convenient decisions.
Clorox (CLX) Q4 Earnings & Sales Beat the Zacks Consensus
by Zacks Equity Research
The Clorox Company (CLX) released 4Q17 results, wherein earnings benefited from strong sales and cost savings. Sales were backed by favorable volumes and pricing.
Archer Daniels (ADM) Q2 Earnings Beat, Revenues Miss Again
by Zacks Equity Research
Archer Daniels Midland Company (ADM) posted 2Q17 results. The bottom line gained from focus on strategic initiatives while sales continued with its dismal surprise trend of over three years.
Amira Nature Foods (ANFI) Catches Eye: Stock Gains 7.9%
by Zacks Equity Research
Amira Nature Foods Ltd. (ANFI) moved big last session, as its shares rose over 7% on the day.
Monsanto (MON) Slips to Hold, Currency & Pricing Woes Linger
by Zacks Equity Research
On Jul 3, Monsanto Company (MON) was downgraded to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
Vale S.A. (VALE) Looks Bearish on Lingering Macro Headwinds
by Zacks Equity Research
On Jun 30, we issued an updated research report on the industrial metals & minerals company, Vale S.A. (VALE).
Monsanto (MON) Tops Q3 Earnings, Confirms FY17 EPS View
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected results for third-quarter fiscal 2017 (ended May 31, 2017).
Archer Daniels (ADM) Stock Continues to Decline: Here's Why
by Zacks Equity Research
Leading food processing company, Archer Daniels Midland Company (ADM) seems to be losing sheen due to back-to-back dismal sales performances.
Archer Daniels (ADM) Lags Q1 Earnings & Sales, Improve Y/Y
by Zacks Equity Research
Archer Daniels (ADM) posted first-quarter 2017 results.
Here's Why You Should Add Colgate Stock to Your Portfolio
by Zacks Equity Research
Colgate (CL) looks good backed by its robust brand strength, capital allocation strategy as well as innovation and in-store implementation initiatives.
Will Archer Daniels' Growth Efforts Help Sustain Momentum?
by Zacks Equity Research
Archer Daniels (ADM) has been undertaking steps to manage its business portfolio and enhancing its global footprint to sustain its momentum.
Earnings Estimates Moving Higher for Limoneira (LMNR): Time to Buy?
by Zacks Equity Research
Limoneira (LMNR) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.
Archer Daniels (ADM) Expands Footprint in Western Europe
by Zacks Equity Research
Archer Daniels Midland Company (ADM) is once again testifying its commitment to enhancing shareholder value through growth and diversification of global sweetener and starch business.
Top Ranked Growth Stocks to Buy for November 3rd
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, November 3rd:
Top Ranked Growth Stocks to Buy for October 31st
by Tirthankar Chakraborty
Here are 4 stocks with buy ranks and strong growth characteristics for investors to consider today, October 31st: